with the authors
Join us for an insightful panel discussion delving into the dynamic landscape of CRT structures and their current role in managing credit and regulatory capital risk effectively within the banking sector.
This event is a must-attend for professionals in finance, law, and investment seeking to gain deeper insights into these innovative capital relief strategies.
Veronica Callahan, partner and Chair of the Securities Enforcement and Litigation Group, will co-chair the ALI-CLE: Accountants’ Liability 2024 conference, which will be held May 16-17, 2024 in Washington, D.C. On May 16, Veronica will speak on the “AI and Emerging Technologies in the Accounting Industry” panel; partner Jane Norberg will speak on the “Proactively Addressing Escalating Issues” panel which will be moderated by partner Christian Schultz; and Dan Hawke will speak on “The Role Auditors Play in Providing Assurance on ESG Issues” panel.
This must-attend annual conference features an unparalleled array of panelists, from noted practitioners, to general counsel from accounting firms, to regulators from the Securities and Exchange Commission (SEC) and the Public Company Accounting Oversight Board (PCAOB).
Please join Arnold & Porter's Government Contracts lawyers in a discussion of the government's small business preference programs focusing on what large businesses, strategic buyers, and financial sponsors need to know about teaming with and acquiring small businesses that contract with the government.
In this webinar, we will provide an overview of the Small Business Administration's contracting programs and the small business and socioeconomic qualification requirements, including recent developments related to the 8(a) program, and then discuss considerations related to small businesses subcontracting plans, limitations on subcontracting under set-aside procurements, mentor-protégé arrangements and associated joint ventures, and diligence and other considerations relevant to acquiring small business government contractors.
Please join us for a webinar for in-house counsel, business development leads, and private equity and venture capital investors focusing on life sciences transactions.
The life sciences industry is heavily regulated and complex with unique legal and business challenges that present both substantial risk and upside. Arnold & Porter partner Hemmie Chang and senior associate Phil DeFedele will discuss how to potentially mitigate and address major FDA regulatory, compliance, and business risks in different life sciences transactions, including:
- Minimizing business risks for pre-commercial assets/targets
- Post-signing/pre-closing risk mitigation
- Regulatory and compliance considerations for integration
- Managing on-going investigations and enforcement
Whether you are focused on life sciences M&A or licensing deals, this program will provide you with insights on how to navigate these complex regulatory and business issues.
Arnold & Porter's Life Sciences Future Forum invites you to an in-person complimentary full-day bootcamp covering the regulatory lifecycle of a medicine in the UK and the EU.
Whether you are new to the regulation of medicines or looking to refresh your knowledge, our life sciences team will take you through key regulatory topics, including:
- Overview of the pharmaceutical legal framework
- Clinical trial regulation
- Promotion and advertising
- Pricing and reimbursement
And much more!
Email
Website
